ORBIMED ADVISORS LLC - Director, 10%+ Owner at ArriVent BioPharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
AVBP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ORBIMED ADVISORS LLC since 12 Mar 2025

Holdings reported by ORBIMED ADVISORS LLC for ArriVent BioPharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,513,664 $5,524,874 $3.65 30 Jan 2024 Indirect
Series A Preferred Stock 0 30 Jan 2024 Indirect Common Stock
Series B Preferred Stock 0 30 Jan 2024 Indirect Common Stock

Transactions reported by ORBIMED ADVISORS LLC for ArriVent BioPharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.